NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Downgraded by ATB Cormark Capital Markets to Sector Perform

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UNGet Free Report) was downgraded by research analysts at ATB Cormark Capital Markets from an “outperform” rating to a “sector perform” rating in a report released on Friday,BayStreet.CA reports. They currently have a C$6.25 price target on the stock. ATB Cormark Capital Markets’ target price points to a potential upside of 7.02% from the company’s previous close.

NWH.UN has been the subject of a number of other research reports. Scotiabank raised their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a report on Thursday, November 13th. Royal Bank Of Canada set a C$5.50 target price on shares of NorthWest Health Prop Real Est Inv Trust and gave the company a “sector perform” rating in a research report on Monday, November 24th. BMO Capital Markets raised their price target on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research report on Thursday, November 13th. Finally, Canadian Imperial Bank of Commerce upped their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research report on Thursday, November 13th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of C$6.04.

View Our Latest Research Report on NorthWest Health Prop Real Est Inv Trust

NorthWest Health Prop Real Est Inv Trust Price Performance

TSE:NWH.UN traded down C$0.18 on Friday, reaching C$5.84. The stock had a trading volume of 797,069 shares, compared to its average volume of 722,084. The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. The company has a market capitalization of C$1.45 billion, a P/E ratio of 28.89, a price-to-earnings-growth ratio of 0.74 and a beta of 1.78. NorthWest Health Prop Real Est Inv Trust has a 1-year low of C$4.44 and a 1-year high of C$6.07. The stock has a fifty day moving average price of C$5.57 and a 200-day moving average price of C$5.27.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UNGet Free Report) last posted its earnings results on Tuesday, February 24th. The company reported C($0.16) earnings per share (EPS) for the quarter. The firm had revenue of C$102.27 million during the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. Research analysts forecast that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current year.

About NorthWest Health Prop Real Est Inv Trust

(Get Free Report)

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

Featured Articles

Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.